Michael C. John

973 total citations
17 papers, 782 citations indexed

About

Michael C. John is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael C. John has authored 17 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Michael C. John's work include Coronary Interventions and Diagnostics (13 papers), Cerebrovascular and Carotid Artery Diseases (8 papers) and Peripheral Artery Disease Management (4 papers). Michael C. John is often cited by papers focused on Coronary Interventions and Diagnostics (13 papers), Cerebrovascular and Carotid Artery Diseases (8 papers) and Peripheral Artery Disease Management (4 papers). Michael C. John collaborates with scholars based in United States, Germany and Switzerland. Michael C. John's co-authors include Renu Virmani, Frank D. Kolodgie, Aloke V. Finn, Andrew Farb, Eduardo Acampado, Gaku Nakazawa, Herman K. Gold, Margaret F. Prescott, Elena Aïkawa and Vasilis Ntziachristos and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Michael C. John

16 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. John United States 11 505 249 224 141 139 17 782
Claudia Abramjuk Germany 13 449 0.9× 180 0.7× 323 1.4× 286 2.0× 140 1.0× 20 887
David Onthank United Kingdom 18 213 0.4× 205 0.8× 267 1.2× 411 2.9× 106 0.8× 35 896
Smbat Amirbekian United States 7 134 0.3× 98 0.4× 236 1.1× 199 1.4× 84 0.6× 12 561
Bock Lim Australia 13 113 0.2× 133 0.5× 109 0.5× 146 1.0× 293 2.1× 16 807
Sylvain Trahan Canada 14 247 0.5× 576 2.3× 411 1.8× 88 0.6× 120 0.9× 39 1.1k
Bettina Schwarz Germany 14 138 0.3× 228 0.9× 105 0.5× 131 0.9× 193 1.4× 20 756
T. Lindhout Netherlands 20 167 0.3× 138 0.6× 128 0.6× 20 0.1× 160 1.2× 29 942
Ashvin N. Pande United States 7 91 0.2× 96 0.4× 92 0.4× 122 0.9× 113 0.8× 8 463
Erxiong Lu China 12 176 0.3× 117 0.5× 59 0.3× 248 1.8× 175 1.3× 20 887
Adelina Curaj Germany 15 125 0.2× 229 0.9× 53 0.2× 69 0.5× 231 1.7× 30 756

Countries citing papers authored by Michael C. John

Since Specialization
Citations

This map shows the geographic impact of Michael C. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. John more than expected).

Fields of papers citing papers by Michael C. John

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. John. The network helps show where Michael C. John may publish in the future.

Co-authorship network of co-authors of Michael C. John

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. John. A scholar is included among the top collaborators of Michael C. John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. John. Michael C. John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Habib, Anwer, Vinit Karmali, Michael C. John, et al.. (2014). Everolimus-Eluting Stents Improve Vascular Response in a Diabetic Animal Model. Circulation Cardiovascular Interventions. 7(4). 526–532. 12 indexed citations
2.
Finn, Aloke V., Jae Sang Oh, Michael J. Hendricks, et al.. (2009). Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo. American Heart Journal. 157(2). 383.e1–383.e8. 9 indexed citations
3.
Finn, Aloke V., Michael C. John, Gaku Nakazawa, et al.. (2009). Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor γ Agonists. Circulation Research. 105(10). 1003–1012. 23 indexed citations
4.
John, Michael C., Rainer Wessely, Adnan Kastrati, et al.. (2008). Differential Healing Responses in Polymer- and Nonpolymer-Based Sirolimus-Eluting Stents. JACC: Cardiovascular Interventions. 1(5). 535–544. 42 indexed citations
5.
Joner, Michael, Hiroaki Kasukawa, Kristin Steigerwald, et al.. (2008). Site-Specific Targeting of Nanoparticle Prednisolone Reduces In-Stent Restenosis in a Rabbit Model of Established Atheroma. Arteriosclerosis Thrombosis and Vascular Biology. 28(11). 1960–1966. 73 indexed citations
6.
Jaffer, Farouc A., Claudio Vinegoni, Michael C. John, et al.. (2008). Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis. Circulation. 118(18). 1802–1809. 152 indexed citations
7.
Nakazawa, Gaku, Aloke V. Finn, Michael C. John, Frank D. Kolodgie, & Renu Virmani. (2007). The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting Stents. The American Journal of Cardiology. 100(8). S36–S44. 106 indexed citations
8.
Jaffer, Farouc A., Matthias Nahrendorf, Claudio Vinegoni, et al.. (2006). Abstract 2036: In Vivo Imaging of Protease Activity in Atherosclerosis Using A Near-Infrared Fluorescence Intravascular Catheter. Circulation. 114. 2 indexed citations
9.
Schmidt, B., et al.. (2005). The Missing Stent – The Most Improbable Complication. Respiration. 72(3). 304–304.
10.
Cheneau, Édouard, Michael C. John, Rosanna Chan, et al.. (2003). Time Course of Stent Endothelialization After Intravascular Radiation Therapy in Rabbit Iliac Arteries. Circulation. 107(16). 2153–2158. 37 indexed citations
11.
John, Michael C., Charanjit Khurana, Frank D. Kolodgie, et al.. (2002). A novel preparation of systemic paclitaxel reduces in-stent restenosis in the rabbit. Journal of the American College of Cardiology. 39. 5–5. 1 indexed citations
12.
Kolodgie, Frank D., Michael C. John, Charanjit Khurana, et al.. (2002). Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel. Circulation. 106(10). 1195–1198. 100 indexed citations
13.
Farb, Andrew, Michael C. John, Eduardo Acampado, et al.. (2002). Oral Everolimus Inhibits In-Stent Neointimal Growth. Circulation. 106(18). 2379–2384. 139 indexed citations
14.
John, Michael C., et al.. (2001). Local arterial responses to 32P β-emitting stents. PubMed. 2(3). 143–150. 6 indexed citations
15.
Farb, Andrew, et al.. (2001). Late Arterial Responses (6 and 12 Months) After 32 P β-Emitting Stent Placement. Circulation. 103(14). 1912–1919. 41 indexed citations
16.
Wess, Günther, Werner Kramer, Alfons Enhsen, et al.. (1993). Synthesis of bile acid - drug conjugates: Potential drug - shuttles for liver specific targeting. Tetrahedron Letters. 34(5). 819–822. 37 indexed citations
17.
John, Michael C., et al.. (1974). Reconstructive Intracranial Vascular Surgery. 10(3). 139–145. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026